September 11, 2019
DKT and Meet Heng to collaborate on women’s health and family planning medicine in Cambodia
Phnom Penh, 11.09.2019 DKT WomenCare, a globally integrated women’s health company providing family planning and safe abortion products in more than 100 countries around the world, and Meet Heng (Cambodia) Ltd. have entered into a collaboration agreement for the marketing and distribution for a number of DKT WomanCare’s medical products in the Kingdom. The collaboration comprises health solutions in the area of contraception, safe deliveries and safe abortions. “As a company focusing on Women’s Health
January 31, 2019
MEET HENG (Cambodia) Ltd. ends 2018 with record sales and strongest Y-o-Y growth in the history of the company
For the Cambodian-German healthcare company Meet Heng, the year 2018 turned out to be one marked by substantial growth and record sales. In its 6th year after founding, the company grew its topline by 65% vs 2017, a number far above market average. “Our strategy of focusing on brand building for existing key products, paired with aggressive portfolio expansion, seems to have paid off in 2018 and we are looking forward to continue on a
January 31, 2019
Meet Heng to collaborate with The Himalaya Drug Company on the commercialisation of 6 herbal health products.
Cambodias’s Meet Heng and India’s The Himalaya Drug Company entered into an agreement for the commercialisation of 6 of Himalayas’ herbal remedies namely, Himcocid Suspension, Rumalaya gel, Bonnisan Suspension, Evecare & V-Gel with an option to further expand the portfolio. “The products that Meet Heng will carry for Himalaya, for very nicely into our pre-existing business units of Women’s Health, Pediatrics and General Medicine, so we are glad to have been able to come to
January 31, 2019
Meet Heng (Cambodia) Ltd. gets regulatory approval for ExEm® Foam Kit, a novel, ultrasound-based contrast media for tubal patency testing.
Cambodian-German healthcare company Meet Heng (Cambodia) Ltd. has received regulatory approval for an innovative contrast media used for tubal patency testing. ExEm® Foam Kit, which is produced by the Dutch medical device incubator company IQ Medical Ventures B.V is indicated for the assessment of the patency of fallopian tubes in an infertility workup. In contrast to traditional techniques used for this diagnostic procedure such as hysterosalpinography or laparoscopy, ExEm® Foam allows for assessment of the